tiprankstipranks
Kobayashi Pharmaceutical Co Ltd (KBYPF)
OTHER OTC:KBYPF
Holding KBYPF?
Track your performance easily

Kobayashi Pharmaceutical Co (KBYPF) Stock Price & Analysis

5 Followers

KBYPF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.45%93.10%
Insiders
― Other Institutional Investors
93.10% Public Companies and
Individual Investors

KBYPF FAQ

What was Kobayashi Pharmaceutical Co Ltd’s price range in the past 12 months?
Kobayashi Pharmaceutical Co Ltd lowest stock price was $31.11 and its highest was $48.51 in the past 12 months.
    What is Kobayashi Pharmaceutical Co Ltd’s market cap?
    Currently, no data Available
    When is Kobayashi Pharmaceutical Co Ltd’s upcoming earnings report date?
    Kobayashi Pharmaceutical Co Ltd’s upcoming earnings report date is Jan 31, 2025 which is in 39 days.
      How were Kobayashi Pharmaceutical Co Ltd’s earnings last quarter?
      Kobayashi Pharmaceutical Co Ltd released its earnings results on Nov 08, 2024. The company reported $0.342 earnings per share for the quarter, missing the consensus estimate of $0.536 by -$0.194.
        Is Kobayashi Pharmaceutical Co Ltd overvalued?
        According to Wall Street analysts Kobayashi Pharmaceutical Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Kobayashi Pharmaceutical Co Ltd pay dividends?
          Kobayashi Pharmaceutical Co Ltd pays a Annually dividend of $0.377 which represents an annual dividend yield of 1.79%. See more information on Kobayashi Pharmaceutical Co Ltd dividends here
            What is Kobayashi Pharmaceutical Co Ltd’s EPS estimate?
            Kobayashi Pharmaceutical Co Ltd’s EPS estimate is $0.51.
              How many shares outstanding does Kobayashi Pharmaceutical Co Ltd have?
              Kobayashi Pharmaceutical Co Ltd has 78,050,000 shares outstanding.
                What happened to Kobayashi Pharmaceutical Co Ltd’s price movement after its last earnings report?
                Kobayashi Pharmaceutical Co Ltd reported an EPS of $0.342 in its last earnings report, missing expectations of $0.536. Following the earnings report the stock price went down -0.028%.
                  Which hedge fund is a major shareholder of Kobayashi Pharmaceutical Co Ltd?
                  Currently, no hedge funds are holding shares in KBYPF
                  ---

                  Kobayashi Pharmaceutical Co Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Company Description

                  Kobayashi Pharmaceutical Co Ltd

                  Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers and skincare. The company's unique strategy of creating and cultivating adjacencies has resulted in over 30% market share in its major categories. Kobayashi mainly sells its products in drugstores, convenience stores and general merchandise stores, or GMSes. It generates around 85% of its sales from Japan, and is expanding overseas business in the U.S., China, and southeast Asia.
                  ---

                  KBYPF Stock 12 Month Forecast

                  Average Price Target

                  $35.91
                  ▼(-4.06% Downside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"30":"$30","39":"$39","48":"$48","34.5":"$34.5","43.5":"$43.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38.35752,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$38.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.325308,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$31.33</span>\n  </div></div>","useHTML":true}}],"tickPositions":[30,34.5,39,43.5,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Sep<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.9,39.78134769230769,39.66269538461538,39.544043076923074,39.425390769230766,39.30673846153846,39.18808615384615,39.06943384615385,38.95078153846154,38.83212923076923,38.713476923076925,38.59482461538462,38.47617230769231,{"y":38.35752,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.9,39.59307692307692,39.286153846153844,38.97923076923077,38.67230769230769,38.36538461538461,38.058461538461536,37.75153846153846,37.44461538461538,37.137692307692305,36.83076923076923,36.52384615384615,36.216923076923074,{"y":35.91,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.9,39.240408307692306,38.58081661538461,37.92122492307692,37.26163323076923,36.602041538461535,35.94244984615385,35.28285815384615,34.62326646153846,33.96367476923077,33.30408307692308,32.644491384615385,31.984899692307692,{"y":31.325308,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":47.38,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.24,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.11,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.03,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.67,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.79,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.08,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.86,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.52,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":39.37,"date":1727395200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":38.79,"date":1728000000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":37.02,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":39.9,"date":1733443200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Takeda Pharmaceutical Company
                  Daiichi Sankyo Company
                  Otsuka Holdings Co
                  Aurinia Pharmaceuticals
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis